| Literature DB >> 27617983 |
Tian-Yu Sun1, Run-Qiao Kuang2, Guo-Dong Chen3, Sheng-Ying Qin4, Chuan-Xi Wang5, Dan Hu6, Bing Wu7, Xing-Zhong Liu8, Xin-Sheng Yao9, Hao Gao10.
Abstract
Three pairs of new isopentenyl dibenzo[b,e]oxepinone enantiomers, (+)-(5S)-arugosin K (1a), (-)-(5R)-arugosin K (1b), (+)-(5S)-arugosin L (2a), (-)-(5R)-arugosin L (2b), (+)-(5S)-arugosin M (3a), (-)-(5R)-arugosin M (3b), and a new isopentenyl dibenzo[b,e]oxepinone, arugosin N (4), were isolated from a wetland soil-derived fungus Talaromyces flavus, along with two known biosynthetically-related compounds 5 and 6. Among them, arugosin N (4) and 1,6,10-trihydroxy-8-methyl-2-(3-methyl-2-butenyl)-dibenz[b,e]oxepin-11(6H)-one (CAS: 160585-91-1, 5) were obtained as the tautomeric mixtures. The structures of isolated compounds were determined by detailed spectroscopic analysis. In addition, the absolute configurations of these three pairs of new enantiomers were determined by quantum chemical ECD calculations.Entities:
Keywords: Talaromyces flavus; arugosins K–N; isopentenyl dibenzo[b,e]oxepinone; wetland soil-derived fungus
Mesh:
Substances:
Year: 2016 PMID: 27617983 PMCID: PMC6274342 DOI: 10.3390/molecules21091184
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Figure 1Production and chemical structures of 1–6.
The 13C- and 1H-NMR data of 1–3 (δ in ppm, J in Hz).
| 1 a | 2 b | 3 a | ||||||
|---|---|---|---|---|---|---|---|---|
| No. | δC | δH | No. | δC | δH c | No. | δC | δH c |
| 1 | 21.8 | 2.37, s | 1 | 21.9 | 2.38, s | 1 | 21.9 | 2.39, s |
| 2 | 147.1 | 2 | 147.2 | 2 | 147.1 | |||
| 3 | 116.8 | 6.94, s | 3 | 116.8 | 6.98, s | 3 | 116.6 | 6.97, s |
| 4 | 138.5 | 4 | 138.8 | 4 | 138.3 | |||
| 5 | 103.4 | 5.64, s | 5 | 102.0 | 5.74, s | 5 | 103.9 | 5.71, s |
| 6 | 154.5 | 6 | 154.8 | 6 | 163.5 | |||
| 7 | 109.3 | 6.58, d (8.3) | 7 | 109.3 | 6.55, d (8.3) | 7 | 112.2 | 6.70, d (8.5) |
| 8 | 137.6 | 7.33, d (8.3) | 8 | 137.6 | 7.32, d (8.3) | 8 | 138.4 | 7.35, d (8.5) |
| 9 | 124.8 | 9 | 124.7 | 9 | 121.8 | |||
| 10 | 162.8 | 10 | 162.7 | 10 | 153.2 | |||
| 11 | 113.6 | 11 | 113.7 | 11 | 113.9 | |||
| 12 | 197.5 | 12 | 197.6 | 12 | 197.5 | |||
| 13 | 116.8 | 13 | 116.9 | 13 | 117.0 | |||
| 14 | 162.4 | 14 | 162.3 | 14 | 161.9 | |||
| 15 | 119.5 | 6.87, s | 15 | 119.4 | 6.86, s | 15 | 119.4 | 6.87, s |
| 1′ | 27.8 | 3.34, d (7.3) | 1′ | 27.8 | 3.35, dd (15.9, 7.4), a | 1′ | 28.0 | 3.36, dd (15.6, 7.5), a |
| 3.31, dd (15.9, 7.4), b | 3.30, dd (15.6, 7.5), b | |||||||
| 2′ | 121.8 | 5.33, br t (7.3) | 2′ | 121.8 | 5.32 | 2′ | 122.1 | 5.25 |
| 3′ | 133.2 | 3′ | 133.3 | 3′ | 133.2 | |||
| 4′ | 25.8 | 1.77, br s | 4′ | 25.8 | 1.76, br s | 4′ | 25.7 | 1.73, br s |
| 5′ | 17.8 | 1.73, br s | 5′ | 17.8 | 1.73, br s | 5′ | 17.8 | 1.71, br s |
| 5-O | 56.9 | 3.57, s | 1′′ | 65.3 | 3.96, dq (9.6, 7.1), a | 5-O | 57.3 | 3.57, s |
| 3.66, dq (9.6, 7.1), b | ||||||||
| 2′′ | 14.8 | 1.26, t (7.1) | ||||||
| 10-O | 13.62, s | 10-O | 13.63, s | 6-O | 13.14, s | |||
| 14-O | 11.46, s | 14-O | 11.44, s | 14-O | 11.22, s | |||
a The data recorded in CDCl3 (1H-NMR for 400 MHz, 13C-NMR for 100 MHz); b The data recorded in CDCl3 (1H-NMR for 600 MHz, 13C-NMR for 150 MHz); c Indiscernible signals owing to overlapping or having complex multiplicity are reported without designating multiplicity. The letters of a and b mean that these two potons on C-1′ are not chemical equivalence.
Figure 2Key 1H-1H COSY and HMBC correlations of 1 and 3.
Figure 3HPLC analysis of 1. a: the analysis of 1 on routine ODS HPLC; b: the analysis of 1 on chiral HPLC.
Figure 4The experimental ECD spectra of 1a and 1b and calculated ECD spectra for (5S)-1 and (5R)-1 (UV correction = −10 nm, band width σ = 0.3 eV).
Figure 5The experimental ECD spectra of 2a, 2b, 1a, and 1b.
Figure 6The experimental ECD spectra of 3a and 3b and calculated ECD spectra for (5S)-3 and (5R)-3 (UV correction = −20 nm, band width σ = 0.3 eV).
The 1H-NMR and 13C-NMR data of 4 and 5 (δ in ppm, J in Hz).
| 4 a | 5 a | ||||
|---|---|---|---|---|---|
| No. | δC | δH | No. | δC | δH |
| 1 | 22.0 | 2.40, s | 1 | 21.9 | 2.40, s |
| 2 | 147.6 | 2 | 147.4 | ||
| 3 | 116.0 | 7.07, s | 3 | 116.2 | 7.04, s |
| 4 | 139.7 | 4 | 139.3 | ||
| 5 | 97.1 | 6.11, s | 5 | 96.6 | 6.12, s |
| 6 | 163.6 | 6 | 154.5 | ||
| 7 | 112.9 | 6.71, d (8.4) | 7 | 109.6 | 6.53, d (8.4) |
| 8 | 138.5 | 7.34, d (8.4) | 8 | 137.7 | 7.32, d (8.4) |
| 9 | 122.4 | 9 | 125.1 | ||
| 10 | 154.0 | 10 | 162.9 | ||
| 11 | 114.6 | 11 | 113.5 | ||
| 12 | 197.3 | 12 | 197.3 | ||
| 13 | 116.5 | 13 | 116.7 | ||
| 14 | 163.3 | 14 | 162.7 | ||
| 15 | 119.8 | 6.89, s | 15 | 119.7 | 6.89, s |
| 1′ | 28.9 | 3.36, dd (15.4, 7.2), a | 1′ | 27.8 | 3.33, d (7.5) |
| 3.22, dd (15.4, 7.2), b | |||||
| 2′ | 123.1 | 5.24, br t (7.2) | 2′ | 121.7 | 5.31, br t (7.5) |
| 3′ | 133.0 | 3′ | 133.4 | ||
| 4′ | 25.7 | 1.76, s | 4′ | 25.8 | 1.76, s |
| 5′ | 18.0 | 1.74, s | 5′ | 17.8 | 1.72, s |
| 6-OH | 12.95, br s | 10-OH | 13.61, br s | ||
| 14-OH | 11.82, br s | 14-OH | 11.54, br s | ||
a The data recorded in CDCl3 (1H-NMR for 400 MHz, 13C-NMR for 100 MHz). The letters of a and b mean that these two potons on C-1′ are not chemical equivalence.
Figure 7The interconversion of 4 and 5.
Scheme 1The plausible biosynthetic pathways of 1–6.